Variant report
Variant | nsv976224 |
---|---|
Chromosome Location | chr13:37849849-37867170 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:37846547..37848688-chr13:37852858..37855009,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566775458 | chr13:37849876-37849877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532437489 | chr13:37849877-37849878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191807389 | chr13:37849893-37849894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567875435 | chr13:37849897-37849898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs537936761 | chr13:37849922-37849923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9576234 | chr13:37850066-37850067 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs184688164 | chr13:37850134-37850135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554871684 | chr13:37850140-37850141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568687706 | chr13:37850200-37850201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534245605 | chr13:37850211-37850212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs77888607 | chr13:37850358-37850359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9547770 | chr13:37850440-37850441 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs35132804 | chr13:37850447-37850448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545049709 | chr13:37850464-37850465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs377146687 | chr13:37850511-37850512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75560408 | chr13:37850528-37850529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9547771 | chr13:37850569-37850570 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs75855988 | chr13:37850576-37850577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560929675 | chr13:37850641-37850642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35567027 | chr13:37850650-37850651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113109920 | chr13:37850654-37850655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542538631 | chr13:37850672-37850673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9547772 | chr13:37850678-37850679 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs189367622 | chr13:37850683-37850684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs560434355 | chr13:37850692-37850693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532351759 | chr13:37850705-37850706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs9576235 | chr13:37850706-37850707 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs543148245 | chr13:37850736-37850737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564945744 | chr13:37850842-37850843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201997233 | chr13:37850861-37850862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562635527 | chr13:37850885-37850886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531692488 | chr13:37850893-37850894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548731923 | chr13:37850926-37850927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34003122 | chr13:37850942-37850943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1951902 | chr13:37850962-37850963 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs560168509 | chr13:37850965-37850966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs78104240 | chr13:37850974-37850975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs74958763 | chr13:37851054-37851055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs17055240 | chr13:37851062-37851063 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs531992580 | chr13:37851169-37851170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538628771 | chr13:37851202-37851203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558595460 | chr13:37851253-37851254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs112598691 | chr13:37851255-37851256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112298143 | chr13:37851331-37851332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537567302 | chr13:37851369-37851370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554715972 | chr13:37851389-37851390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs574533090 | chr13:37851458-37851459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540450899 | chr13:37851499-37851500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560015144 | chr13:37851518-37851519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192698858 | chr13:37851533-37851534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Prostate cancer | 21965145 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Monoclonal gammopathy of undetermined significance | 19135901 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 17440070 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:37849200-37852000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr13:37849800-37850000 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr13:37849800-37850000 | Enhancers | NHDF-Ad | bronchial |
4 | chr13:37850800-37851200 | Enhancers | Colon Smooth Muscle | Colon |
5 | chr13:37851000-37851800 | Enhancers | HMEC | breast |
6 | chr13:37851200-37851600 | Enhancers | Fetal Heart | heart |
7 | chr13:37851200-37851800 | Enhancers | Osteobl | bone |
8 | chr13:37851200-37852000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr13:37851200-37852200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr13:37851400-37852000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr13:37851800-37852200 | Enhancers | NHEK | skin |
12 | chr13:37852200-37860200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr13:37859000-37859800 | Enhancers | Muscle Satellite Cultured Cells | -- |
14 | chr13:37859000-37863400 | Enhancers | HUVEC | blood vessel |
15 | chr13:37860200-37861400 | Strong transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
16 | chr13:37861400-37862200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
17 | chr13:37861400-37877200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr13:37862200-37862400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
19 | chr13:37862200-37862600 | Enhancers | Fetal Muscle Leg | muscle |
20 | chr13:37862400-37862600 | Enhancers | Adipose Nuclei | Adipose |
21 | chr13:37862400-37863400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
22 | chr13:37863200-37864200 | Enhancers | Brain Substantia Nigra | brain |
23 | chr13:37863400-37863800 | Enhancers | Fetal Heart | heart |
24 | chr13:37863400-37864000 | Enhancers | Brain Hippocampus Middle | brain |
25 | chr13:37863400-37865200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |